Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Shandong Boan Biotechnology Company., Limited. Class H ( (HK:6955) ) has provided an announcement.
Shandong Boan Biotechnology announced the current composition of its Board of Directors, which includes executive, non-executive, and independent non-executive directors, reflecting a diversified governance structure. The company also detailed the membership and leadership of its five key board committees—Audit, Remuneration, Nomination, Strategy, and Environmental, Social and Governance—clarifying oversight responsibilities and reinforcing its corporate governance framework for investors and other stakeholders.
More about Shandong Boan Biotechnology Company., Limited. Class H
Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company based in the People’s Republic of China and listed in Hong Kong under stock code 6955. The company operates in the biotechnology and pharmaceutical industry, focusing on the research, development, and commercialization of innovative therapies for the healthcare market.
Average Trading Volume: 5,828,037
Technical Sentiment Signal: Sell
Current Market Cap: HK$4.35B
See more insights into 6955 stock on TipRanks’ Stock Analysis page.